EMBO Reports
EMBO reports
SEARCH
My AccountSubmit manuscriptSubscribeRegisterHelp
Journal home
Press releases
Aims and scope
Authors and referees
 Guide for authors
 Guide for referees
 Contact editors
 Advisors & Advisory
 Editorial Board
 Submit a Manuscript
Customer Services
 Subscriptions
 Order sample copy
 Purchase articles
 Reprints and
  permissions
 Contact NPG
 Advertising
EMBO
EMBO
www.embo.org

go to prev issue previous - ISSUE - next go to next issue
EMBO Reports Journal Cover

Contents: Volume 5,
Number S1
 
go to science & society
Sign up for eTOCs
Sign upReceive this page by email each issue
science and society
Degrees of Risk.

Holger Breithaupt, Frank Gannon & Caroline Hadley

EMBO reports 5, S1, S1–S3 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400265
Science policy for risk governance.  Rather than regarding risk governance as a burden, science should embrace it as an opportunity to build public trust

José Mariano Gago

EMBO reports 5, S1, S4–S6 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400264
Pascal's legacy.  The musings of a Belgian monk 300 years ago on the consequences of believing in God, or not, have influenced our Western life probably more than any other scientific or technological invention

John F. Ross

EMBO reports 5, S1, S7–S10 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400229
Globalization and risks to health.  As borders disappear, people and goods are increasingly free to move, creating new challenges to global health. These cannot be met by national governments alone but must be dealt with instead by international organizations and agreements

Tikki Pang & G. Emmanuel Guindon

EMBO reports 5, S1, S11–S16 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400226
The real and perceived risks of genetically modified organisms.  The debate about the potential risks of genetically modified organisms has lasted for almost three decades without any final conclusion in sight. Why is it that the public remains critical of this technology even though science has so far not demonstrated any tangible risks to human health and the environment?

Helge Torgersen

EMBO reports 5, S1, S17–S21 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400231
The prediction of disease risk in genomic medicine.  Scientific prospects and implications for public policy and ethics

Wayne D. Hall, Katherine I. Morley & Jayne C. Lucke

EMBO reports 5, S1, S22–S26 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400224
The risks of eating and drinking.  Consumer perceptions and 'reality'

Susan B.T. Wilkinson, Gene Rowe & Nigel Lambert

EMBO reports 5, S1, S27–S31 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400225
The case of nanobiotechnology.  Towards a prospective risk assessment

Armin Grunwald

EMBO reports 5, S1, S32–S36 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400223
Hormesis: a revolution in toxicology, risk assessment and medicine.  Re-framing the dose–response relationship

Edward J. Calabrese

EMBO reports 5, S1, S37–S40 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400222
Systemic risks: a new challenge for risk management.  As risk analysis and risk management get increasingly caught up in political debates, a new way of looking at and defining the risks of modern technologies becomes necessary

Ortwin Renn & Andreas Klinke

EMBO reports 5, S1, S41–S46 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400227
Principles of risk perception applied to gene technology.  To overcome the resistance to applications of biotechnology, research on risk perception must take a closer look at the public's reasons for rejecting this technology

Lennart Sjöberg

EMBO reports 5, S1, S47–S51 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400258
Science in a political environment.  The dynamics of research, risk perception and policy making

Peter Weingart

EMBO reports 5, S1, S52–S55 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400230
The consequences of fear.  Our modern world is a risky place and evokes many well-founded fears. But these fears themselves create a new risk for our health and well-being that needs to be addressed

David Ropeik

EMBO reports 5, S1, S56–S60 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400228
When even the 'best-laid' plans go wrong.  Strategic risk communication for new and emerging risks

Katherine McComas

EMBO reports 5, S1, S61–S65 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400257
Risk and the law.  Scientists do not necessarily like the restrictions and regulations of biotechnology, but they need to accept that lawmakers must reflect the wishes and demands of the majority of the population, who are increasingly aware of the potential risks

Julian Kinderlerer

EMBO reports 5, S1, S66–S70 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400259
top go to top
Privacy PolicyCopyright © 2004 by the European Molecular Biology Organization